| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
This report compares the use of the lactate dehydrogenase (pLDH) assay with 3H-hypoxanthine incorporation and Giemsa microscopy for the evaluation of anti-malaria drug inhibition of the growth of P. falciparum in vitro. The inhibition profiles and IC50 determinations of the pLDH assay were directly comparable to those determined by the radioactive uptake and microscopic methods. Furthermore, the pLDH culture sensitivity assay is reproducible, easily interpreted, rapid and inexpensive to perform, suggesting field applicability.
This article has been cited by other articles:
|
|
 |
|
  E. Cunningham, M. Drag, P. Kafarski, and A. Bell Chemical Target Validation Studies of Aminopeptidase in Malaria Parasites Using {alpha}-Aminoalkylphosphonate and Phosphonopeptide Inhibitors Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3221 - 3228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Liu, J. Mu, H. Jiang, and X.-z. Su Effects of Plasmodium falciparum Mixed Infections on In Vitro Antimalarial Drug Tests and Genotyping Am J Trop Med Hyg, August 1, 2008; 79(2): 178 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. S. S. Kantamreddi and C. W. Wright Investigation of Indian Diospyros Species for Antiplasmodial Properties Evid. Based Complement. Altern. Med., June 1, 2008; 5(2): 187 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Lazarus, T. G. Schneider, and T. F. Taraschi A new model for hemoglobin ingestion and transport by the human malaria parasite Plasmodium falciparum J. Cell Sci., June 1, 2008; 121(11): 1937 - 1949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Barthel, M. Schlitzer, and G. Pradel Telithromycin and Quinupristin-Dalfopristin Induce Delayed Death in Plasmodium falciparum Antimicrob. Agents Chemother., February 1, 2008; 52(2): 774 - 777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Singh, A. Agarwal, S. I. Khan, L. A. Walker, and B. L. Tekwani Growth, Drug Susceptibility, and Gene Expression Profiling of Plasmodium falciparum Cultured in Medium Supplemented with Human Serum J Biomol Screen, December 1, 2007; 12(8): 1109 - 1114. [Abstract] [PDF]
|
|
|
|
|
|
J. D. Johnson, R. A. Dennull, L. Gerena, M. Lopez-Sanchez, N. E. Roncal, and N. C. Waters Assessment and Continued Validation of the Malaria SYBR Green I-Based Fluorescence Assay for Use in Malaria Drug Screening Antimicrob. Agents Chemother., June 1, 2007; 51(6): 1926 - 1933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. NKHOMA, M. MOLYNEUX, and S. WARD IN VITRO ANTIMALARIAL SUSCEPTIBILITY PROFILE AND PRCRT/PFMDR-1 GENOTYPES OF PLASMODIUM FALCIPARUM FIELD ISOLATES FROM MALAWI Am J Trop Med Hyg, June 1, 2007; 76(6): 1107 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Bacon, C. Latour, C. Lucas, O. Colina, P. Ringwald, and S. Picot Comparison of a SYBR Green I-Based Assay with a Histidine-Rich Protein II Enzyme-Linked Immunosorbent Assay for In Vitro Antimalarial Drug Efficacy Testing and Application to Clinical Isolates Antimicrob. Agents Chemother., April 1, 2007; 51(4): 1172 - 1178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Gavigan, M. Shen, S. G. Machado, and A. Bell Influence of the Plasmodium falciparum P-glycoprotein homologue 1 (pfmdr1 gene product) on the antimalarial action of cyclosporin J. Antimicrob. Chemother., February 1, 2007; 59(2): 197 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kaddouri, S. Nakache, S. Houze, F. Mentre, and J. Le Bras Assessment of the Drug Susceptibility of Plasmodium falciparum Clinical Isolates from Africa by Using a Plasmodium Lactate Dehydrogenase Immunodetection Assay and an Inhibitory Maximum Effect Model for Precise Measurement of the 50-Percent Inhibitory Concentration. Antimicrob. Agents Chemother., October 1, 2006; 50(10): 3343 - 3349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. M. Persson, C. T. Lee, K. Marsh, and J. G. Beeson Development and Optimization of High-Throughput Methods To Measure Plasmodium falciparum-Specific Growth Inhibitory Antibodies. J. Clin. Microbiol., May 1, 2006; 44(5): 1665 - 1673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. AYALA, A. G. LESCANO, R. H. GILMAN, M. CALDERON, V. V. PINEDO, H. TERRY, L. CABRERA, and J. M. VINETZ POLYMERASE CHAIN REACTION AND MOLECULAR GENOTYPING TO MONITOR PARASITOLOGICAL RESPONSE TO ANTI-MALARIAL CHEMOTHERAPY IN THE PERUVIAN AMAZON Am J Trop Med Hyg, April 1, 2006; 74(4): 546 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cameron, J. Read, R. Tranter, V. J. Winter, R. B. Sessions, R. L. Brady, L. Vivas, A. Easton, H. Kendrick, S. L. Croft, et al. Identification and Activity of a Series of Azole-based Compounds with Lactate Dehydrogenase-directed Anti-malarial Activity J. Biol. Chem., July 23, 2004; 279(30): 31429 - 31439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Fennell, S. Carolan, G. R. Pettit, and A. Bell Effects of the antimitotic natural product dolastatin 10, and related peptides, on the human malarial parasite Plasmodium falciparum J. Antimicrob. Chemother., April 1, 2003; 51(4): 833 - 841. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
